New Year • New Program For nearly a decade, HollisterStier Allergy’s BeeAware program has helped educate patients and physicians about venom immunotherapy. We are excited to announce the roll-out of our refreshed BeeAware program and the launch of a fresh and updated website. Patient education delivered in a new and improved package The BeeAware program…
Details
Read as letter Read related AAAAI/ACAAI email to members At the end of February 2018, we learned that we will be the only supplier of venom immunotherapy products in North America. In light of this situation, we have evaluated our production capabilities as they relate to our ability to indefinitely supply the entire North American…
Details
It may be AP Dog if he’s allergic to his canine companion. According to the U.S. Pet Ownership & Demographics Sourcebook (2012), there is at least one dog living in over 36 percent of US households. That translates to 43,346,000 homes with at least one dog in residence. While only 10 percent1 of people are allergic to them,…
Details
January 22, 2018 – Jubilant Pharma announces the appointment of Chris Preti to the position of President for its allergy company, HollisterStier Allergy. Mr. Preti has over 25 years of progressive pharmaceutical experience. He began his career at GlaxoSmithKline in research and development, developing products for regulatory submission across multiple therapeutic areas. He then joined…
Details
Joint Message Announcing Venom Extract Shortage Task Force Report The AAAAI and ACAAI previously announced a venom extract shortage due to ALK – Abello A/S experiencing a manufacturing delay in regards to its venom products. In response, we formed a task force of experts to generate guidance outlining recommendations for our members which could lead…
Details